ClinicalMetric / Countries / Japan / factor xa inhibitor
← 🇯🇵 Japan Trials
🇯🇵 Japan Country × Condition

factor xa inhibitor Clinical Trials in Japan

Active clinical trials for factor xa inhibitor with research sites in Japan. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇯🇵 Japan

Active Trials in Japan (1)

NCT05454787
Recruiting

Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All Case Investigation)

Enrollment
300 pts
Country
🇯🇵 Japan
AstraZeneca
View Trial →

Frequently Asked Questions

How many factor xa inhibitor clinical trials are active in Japan?
There are currently 1 active clinical trials for factor xa inhibitor with sites in Japan, of which 1 are actively recruiting patients.
How can I join a factor xa inhibitor clinical trial in Japan?
To join a factor xa inhibitor clinical trial in Japan, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Japan directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are factor xa inhibitor trials in Japan?
Active factor xa inhibitor trials in Japan span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Japan Trials → Global factor xa inhibitor Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology